XSPRAY PHARMA AB NPVXSPRAY PHARMA AB NPVXSPRAY PHARMA AB NPV

XSPRAY PHARMA AB NPV

No trades
See on Supercharts

0GHZ fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Xspray Pharma AB is a pharmaceutical company, which develops and produces product candidates in clinical development phase. It uses its innovative, patented technology to develop amorphous product candidates that are improved versions of marketed drugs, primarily protein kinase inhibitors, for the treatment of cancer. Its product portfolio includes candidates based on the firm's HyNap platform: Dasynoc, HyNap-Nilo, and HyNap-Sora. The company was founded by Mustafa Demirbüker and Håkan Nykvist in November 2003 and is headquartered in Solna, Sweden.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

0GHZ does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company